Overview Financials News + Filings Key Docs Ownership
|
|
RedHill Biopharma Ltd. (RDHL)
|
|
| Balance Sheet |
|
|
|
| Standardized | As Reported |
Annual | Quarterly |
|
| In millions, except per share items | Mar-31-21 | Dec-31-20 | Sep-30-19 | Mar-31-19 | Dec-31-18 | Mar-31-18 | Dec-31-17 | Dec-31-16 |
| | 6-K | | 6-K | 6-K | | 6-K | | |
| Assets |
| Cash and equivalents | 76.0 | | 11.6 | 23.0 | | 7.6 | | |
| Accounts receivable, net | 23.3 | | 0.9 | 1.4 | | 1.8 | | |
| Inventories | 9.3 | | 2.0 | 1.3 | | 0.6 | | |
| Other current assets | 20.3 | | 2.3 | 1.2 | | 2.0 | | |
| Total current assets | 128.8 | | 16.8 | 27.0 | | 11.9 | | |
| Intangibles | 86.1 | | 5.3 | 5.3 | | 5.3 | | |
| Total assets | 220.1 | | 40.2 | 58.1 | | 46.4 | | |
| |
| Accounts payable | 6.5 | | 4.8 | 4.4 | | 2.7 | | |
| Accrued expenses | 25.4 | | 8.1 | 7.0 | | 6.5 | | |
| Short-term debt | 0.0 | | 0.0 | 0.0 | | 0.0 | | |
| Total current liabilities | 32.0 | | 12.9 | 11.4 | | 9.2 | | |
| Other liabilities | 135.1 | | 4.5 | 4.9 | | 0.9 | | |
| Total liabilities | 167.1 | | 17.4 | 16.3 | | 10.1 | | |
| |
| Shareholders' equity [+] | 53.0 | | 22.9 | 41.9 | | 36.3 | | |
| Paid-in capital | 354.1 | | 219.5 | 219.5 | | 177.8 | | |
| Retained earnings | -302.3 | | -197.4 | -178.4 | | -142.1 | | |
| Tangible shareholders' equity | -33.0 | | 17.5 | 36.6 | | 31.0 | | |
|